Urea/DTT solubilization of a recombinant Taenia ovis antigen, 45W, expressed as a GST fusion protein results in enhanced protective immune response to the 45W moiety

Author： Rothel J.S.   Wood P.R.   Seow H.-F.   Lightowlers M.W.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.15, Iss.5, 1997-04, pp. : 469-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the - Taenia ovis 45W antigen

By Drew D.R.   Lightowlers M.   Strugnell R.A.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2522-2532

Elsevier

Access to resources Recommend Favorite

The influence of gamma inulin and Algammulin on the immune response in sheep to a recombinant antigen of Taenia ovis

By Deol H.S.   Dunsmore T.   Carnegie P.R.   Palmer D.G.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 429-433

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

Immune response to baculovirus expressed protein fragment amino acids 190-289 of respiratory syncytial virus (RSV) fusion protein

By Werle B.   Bourgeois C.   Alexandre A.   Massonneau V.   Pothier P.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1127-1130

Elsevier

Access to resources Recommend Favorite

Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii

By Kedzierski L.   Black C.G.   Stowers A.W.   Goschnick M.W.   Kaslow D.C.   Coppel R.L.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4661-4668

Elsevier

Access to resources Recommend Favorite